Proof of Usefulness Report

Clinical Accelerator

Analysis completed on 2/13/2026

+464
Proof of Usefulness Score
Industry Mainstay

Clinical Accelerator appears to be a legitimate, established Contract Research Organization (CRO) with a significant operational history (since 2006) and a reported team size of 125, suggesting strong real-world traction ($17M revenue/valuation implied). However, the submission quality is critically low, containing demonstrably false claims (e.g., 'most people have used my product' for a B2B niche service) and generic data. The score benefits heavily from the underlying business fundamentals but is significantly penalized for the lack of accurate, verifiable detail and unprofessional presentation.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+21.25
Audience Reach Impact+4.0
Technical Innovation+3.0
Evidence Of Traction+16.0
Market Timing Relevance+7.0
Functional Completeness+0.25
Subtotal+51.5
Usefulness Multiplierx0.90
Final Score+464

Project Details

Description
Clinical Accelerator is an academically linked clinical CRO and a patient enrolment organization. We focus primarily on clinical trials with novel medical devices, conducting all types of clinical investigations for international medtech companies, including first-in-human, early human feasibility studies, pivotal and post-marketing trials. Clinical Accelerator is active in all main therapeutic areas with a special focus on the cardiovascular field. Other important indications include neurovascular, interventional pulmonology, orthopedic, dermatology and women’s health. We closely collaborate with many distinguished international KOLs in these therapeutic areas. We are specialists in effective and timely patient recruitment, and commit to achieving patient enrolment targets within fixed timelines. Placing clinical trials in our Eastern European countries of operation such as Georgia, Lithuania, Uzbekistan, Czech Republic, Armenia, Bulgaria etc. allows Clinical Accelerator to achieve significant cost savings for our clients and to utilize regulatory advantages existing in some of these locations. Fast and efficient patient recruitment is another important advantage. To ensure excellent quality of our Eastern European trials, we carefully select sites and investigators able to work to the highest quality standards. We deliver affordable clinical trials solutions with quality and speed!

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline